Demand, appropriateness and prescribing of 'lifestyle drugs': a consultation survey in general practice | Zendy

Mark Ashworth | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Demand, appropriateness and prescribing of 'lifestyle drugs': a consultation survey in general practice

Author(s) -

Mark Ashworth

Publication year - 2002

Publication title -

family practice

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.955

H-Index - 100

eISSN - 1460-2229

pISSN - 0263-2136

DOI - 10.1093/fampra/19.3.236

Subject(s) - orlistat , medicine , medical prescription , sildenafil , family medicine , observational study , primary care , general practice , nursing , obesity , weight loss

The simultaneous launch of orlistat and sildenafil in 1998 provoked much media attention, particularly around the role of lifestyle drugs and their potential costs if controls were not established. Fears were also expressed that primary care would be overwhelmed by demand, and little information was available about the attitude of GPs to their new role as prescribers of lifestlye drugs. Partly in response to these concerns, tight prescribing guidelines and licensed indications, for sildenafil and orlistat, respectively, were issued.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research